Klinik Atölye

Akciğer enfeksiyonları · Taklitçi · Orta öncelik

Organize pnömoni paterni

Organizing pneumonia pattern

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez.

Organize pnömoni paterni: yayımlanmış olgu görüntüsü, aksiyel kesit

4 adım

Görüntü: Gomes R, Padrão E, Dabó H ve ark., “Acute fibrinous and organizing pneumonia: A report of 13 cases in a tertiary university hospital.” 2016, Figure 2. PMC5058823 · doi:10.1097/md.0000000000004073 · CC BY 4.0. Değişiklik: kırpıldı, yeniden boyutlandırıldı, odak işaretleri eklendi.

Özet

Organize pnömoni, enfeksiyon sonrası, ilaç, bağ dokusu hastalığı veya başka akciğer hasarlarıyla ilişkili olabilen bir akciğer hasarı yanıtıdır; kriptojenik biçimi de bulunur. BT'de yamalı konsolidasyon ve buzlu cam opasitelerinin plevra altı ya da bronkovasküler dağılımını gösterir, ancak görünüm tek başına nedeni kanıtlamaz. Ters halo ve lezyonların zaman içinde yer değiştirmesi tanıyı akla getirebilir; bunlar özgül işaret değildir. Enfeksiyon veya tümörün organize pnömoni sanılması uygun tanısal değerlendirmeyi geciktirebilir.

Faz ve pencere

İnce kesit (HRCT) tanısal
Organize pnömoni örüntüsünde periferik veya peribronkovasküler buzlu cam opasiteleri ve konsolidasyonlar ile perilobüler opasiteler ve ters halo görülebilir; ters halo, merkezî buzlu camı hilal ya da halka biçimli konsolidasyonun çevrelediği görünümdür.
Kontrastsız
Aynı parankimal opasiteler ve dağılım seçilebilir; kontrastsız kesitler örüntüyü tanımlar fakat organizasyonu veya altta yatan nedeni tek başına doğrulamaz.

Önerilen pencereler: Akciğer (G 1500 / M -600).

BT bulguları

  • Organize pnömonide subplevral konsolidasyonlar hava bronkogramı içerebilir.
  • Plevra altı, bronkovasküler ya da her iki dağılımda alveoler opasiteler
  • Konsolidasyonla komşu veya ayrı alanlarda buzlu cam dansiteleri
  • Ters halo (atoll) işareti — merkezde buzlu cam, çevresinde kısmi veya tam konsolidasyon halkası
  • İkincil pulmoner lobül çevresini izleyen kavisli perilobüler opasiteler
  • Önceki incelemeye göre gerileyen bir opasite alanıyla birlikte başka lobda yeni konsolidasyon odağı
  • Organize pnömoni örüntüsünde perilobüler kalınlaşma, traksiyon bronşektazisi veya fokal hacim kaybı görülebilir.

Normalde

Organize pnömoni örüntüsünde buzlu cam opasiteleri ve küçük konsolidasyonlar periferik veya peribronkovasküler dağılım gösterebilir; opasitelerin plevraya ve bronkovasküler demete göre dağılımını kaydet.

Normal BT ile kıyasla

Aynı bölgenin, kaynak veri setinde patoloji içermediği belirtilen bir BT incelemesini kesit kesit kaydırın; organ sınırlarını açarak anatomiyi hasta görüntüsüyle karşılaştırın. Küçük rastlantısal bulgular tümüyle dışlanmamıştır.

Kaynak: TotalSegmentator v2.01 veri seti (Wasserthal ve ark., Radiology: Artificial Intelligence 2023), CC BY 4.0, vaka s1278; organ sınırları veri setinin otomatik segmentasyonundan, birleştirilerek sadeleştirildi. Görüntüler 2,5 mm kesit aralığına yeniden örneklendi.

Ayırıcı tanı

Lober bakteriyel pnömoni
segment/lob sınırına oturan daha yoğun hava boşluğu konsolidasyonu ve klinik enfeksiyon bulguları öne çıkar; göç eden odaklar tipik değildir.
Ters halo işareti organize pnömoniye özgü değildir; enfeksiyöz ve enfeksiyon dışı akciğer hastalıklarında da görülebilir.
Pulmoner ödem ayırıcı tanısında düzgün interlobüler septal kalınlaşma görülebilir.
Eozinofilik pnömoni
kronik eozinofilik pnömonide bilateral periferik ağırlıklı konsolidasyon ve/veya buzlu cam opasiteleri görülebilir; histopatolojide organize pnömoni paterni eşlik edebilir.
Akciğer kanseri organize pnömoniyi taklit edebilir; organize pnömoni tanısı belirsiz olduğunda histopatolojik doğrulama gerekebilir.

Tuzaklar

  • Ters halo işareti kriptojenik organize pnömoniye özgü değildir; halkanın nodüler iç kenarı, çevre nodüller ve kavite invaziv enfeksiyonu öne çıkarabilir.
  • Bir tek BT'de 'göç' saptanamaz; eski incelemeyle yan yana bakıp gerileyen ve yeni beliren odakları ayrı ayrı doğrula.
  • Perilobüler kavisleri gerçek interlobüler septal kalınlaşma sanma; opasitenin aynı alanda buzlu cam/konsolidasyonla birlikte lobül dış sınırını izlemesi organizasyon örüntüsünü destekler.

Kendini dene

  1. Öksürüğü olan hastada iki taraflı, yamalı subplevral opasiteler var; önceki konsolidasyon gerilerken başka lobda yenisi ortaya çıkmış. Örüntü hangisini destekler?

    Cevabı göster

    Organize pnömoni. Dağılımın yamalı olması ve farklı zamanlarda başka bölgelerde belirmesi organize pnömoni paternini destekler. Lober pnömoni çoğunlukla tek anatomik lobda yoğunlaşır; ödemde septal ve vasküler eşlikçiler aranır, aspergilloz için nodüler halo/kavite ve risk bağlamı önemlidir.

  2. Ters halo halkasının içinde ve çevresinde küçük nodüller ile bir kavite fark ediliyor. Hangi olasılık özellikle yeniden düşünülmelidir?

    Cevabı göster

    İnvaziv fungal enfeksiyon. Nodüler halka ve kavite, immün baskılanma bağlamında invaziv fungal enfeksiyon lehine uyarıcı morfolojik işaretlerdir. Organize pnömonide ters halo görülebilir, fakat bu görünüm tek başına özgül değildir; ödem ve atelektazi bu nodüler kavite paternini açıklamaz.

İlgili konular

Kaynaklar

Bu sayfadaki 35 cümle ve 2 quiz sorusu aşağıdaki kaynaklardan alıntılarla otomatik olarak karşılaştırıldı; 4 cümle bu karşılaştırmada düzeltildi (2026-10-09).

  1. Pictorial guide for variants of Covid-19: CT imaging and interpretationpmc.ncbi.nlm.nih.gov
  2. An Integrated Radiologic-Pathologic Understanding of COVID-19 Pneumoniapmc.ncbi.nlm.nih.gov
  3. Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Reviewpmc.ncbi.nlm.nih.gov
  4. Chronic Eosinophilic Pneumonia: A Diagnostic Challenge With Atypical Bronchoalveolar Lavage Findings and an Organizing Pneumonia Patternpmc.ncbi.nlm.nih.gov
  5. A Mimic of Metastatic Malignancy: Dietary Supplement‐Associated Drug‐Induced Lung Injury Presenting as Multiple Pulmonary Nodules With an Acute Fibrinous and Organizing Pneumonia Patternpmc.ncbi.nlm.nih.gov
  6. Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management?pubmed.ncbi.nlm.nih.gov
  7. Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Review.pubmed.ncbi.nlm.nih.gov
  8. Pictorial guide for variants of Covid-19: CT imaging and interpretation.pubmed.ncbi.nlm.nih.gov
  9. An Integrated Radiologic-Pathologic Understanding of COVID-19 Pneumonia.pubmed.ncbi.nlm.nih.gov
  10. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.pubmed.ncbi.nlm.nih.gov
  11. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings.pubmed.ncbi.nlm.nih.gov
  12. Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis.pubmed.ncbi.nlm.nih.gov
  13. Clinical-imaging characteristics and management of anti-JO-1 and non-JO-1 anti-synthetase syndrome-associated interstitial lung disease.pubmed.ncbi.nlm.nih.gov
  14. Focal organizing pneumonia simulating lung malignancy: treated with prednisolone.pubmed.ncbi.nlm.nih.gov
  15. Temporal changes of lung computed tomography findings pulmonary COVID-19 infection.pubmed.ncbi.nlm.nih.gov
  16. Everolimus-induced pneumonitis in neuroendocrine neoplasms: correlation of CT findings and clinical signs.pubmed.ncbi.nlm.nih.gov
  17. Nivolumab-induced interstitial lung disease in a patient with gastric cancer.pubmed.ncbi.nlm.nih.gov
  18. A case of vildagliptin-induced interstitial pneumonia.pubmed.ncbi.nlm.nih.gov
  19. An unusual radiologic manifestation of hypersensitivity pneumonia.pubmed.ncbi.nlm.nih.gov
  20. Potential association of bronchoalveolar lavage lipid-laden macrophages with disease severity and corticosteroid response in interstitial lung disease: a pilot study.pubmed.ncbi.nlm.nih.gov
  21. Characteristics, prognosis, and risk factors for relapse in patients with cryptogenic organizing pneumonia: A prospective cohort study in China.pubmed.ncbi.nlm.nih.gov
  22. A Mimic of Metastatic Malignancy: Dietary Supplement-Associated Drug-Induced Lung Injury Presenting as Multiple Pulmonary Nodules With an Acute Fibrinous and Organizing Pneumonia Pattern.pubmed.ncbi.nlm.nih.gov
  23. <i>Aspergillus fumigatus</i>-induced acute fibrinous and organizing pneumonia complicated by spontaneous subcutaneous and mediastinal emphysema: a case report and literature review.pubmed.ncbi.nlm.nih.gov
  24. Chronic Eosinophilic Pneumonia: A Diagnostic Challenge With Atypical Bronchoalveolar Lavage Findings and an Organizing Pneumonia Pattern.pubmed.ncbi.nlm.nih.gov
  25. From imaging clue to diagnosis: <i>Pseudomonas putida</i> pneumonia with the reversed halo sign-navigating diagnosis and treatment.pubmed.ncbi.nlm.nih.gov
  26. Lipoid Pneumonia: HRCT and MRI Spectrum, Diagnostic Pitfalls, and Imaging-Based Diagnostic Workflow.pubmed.ncbi.nlm.nih.gov
  27. New insights into imaging of pulmonary metastases from extra-thoracic neoplasms.pubmed.ncbi.nlm.nih.gov
  28. Acute and chronic eosinophilic pneumonia: an overview.pubmed.ncbi.nlm.nih.gov
  29. Pulmonary tularemia presenting as bilateral pulmonary nodules during BEP chemotherapy for testicular embryonal carcinoma: A diagnostic challenge.pubmed.ncbi.nlm.nih.gov
  30. Case Report: Invasive mucinous adenocarcinoma mimicking interstitial pneumonia with autoimmune features: diagnostic pitfalls and reflections.pubmed.ncbi.nlm.nih.gov
  31. Metastatic Breast Cancer Presenting as an Organizing Pneumonia Pattern on Chest CT: A Case Report.pubmed.ncbi.nlm.nih.gov
  32. Uncommon Causes of Interlobular Septal Thickening on CT Images and Their Distinguishing Features.pubmed.ncbi.nlm.nih.gov
  33. Autoimmune Pulmonary Alveolar Proteinosis in a Patient With Chronic Disseminated Blastomycosis: A Case Report.pubmed.ncbi.nlm.nih.gov
  34. Quantitative spectral computed tomography biomarkers for idiopathic inflammatory myopathy-associated interstitial lung disease: a dual-layer detector computed tomography study.pubmed.ncbi.nlm.nih.gov
  35. How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients.pubmed.ncbi.nlm.nih.gov
  36. Drug-Induced Interstitial Lung Disease in Lung Cancer Patients.pubmed.ncbi.nlm.nih.gov
  37. Radiation Recall Pneumonitis: Imaging Appearance and Differential Considerations.pubmed.ncbi.nlm.nih.gov
  38. The many faces of cryptogenic organizing pneumonia (COP).pubmed.ncbi.nlm.nih.gov
  39. Amiodarone-induced granulomatous lung injury mimicking organizing pneumonia: a case report.pubmed.ncbi.nlm.nih.gov
  40. Primary Biliary Cholangitis-Associated Granulomatous Interstitial Lung Disease: Pulmonary Epithelial-Interface Injury Supporting the Concept of Generalized Autoimmune Epithelitis.pubmed.ncbi.nlm.nih.gov
  41. Management of pneumonia by the emergency radiologist.pubmed.ncbi.nlm.nih.gov
  42. Radiologic patterns of interstitial lung disease: a pictorial review based on the 2025 European Respiratory Society/American Thoracic Society Classification.pubmed.ncbi.nlm.nih.gov
  43. Case Report: The "atoll sign": a case series on an unusual radiological pattern of immune-mediated pneumonitis.pubmed.ncbi.nlm.nih.gov
  44. Distinguishing Organizing Pneumonia from Malignancy During Cancer Surveillance: Predominant Diagnostic Value of Imaging over Systemic Inflammatory Biomarkers.pubmed.ncbi.nlm.nih.gov
  45. The reverse halo sign in emergency chest CT: A diagnostic guide across diverse pulmonary conditions.pubmed.ncbi.nlm.nih.gov
  46. Comprehensive radiologic-pathologic correlation in systemic sclerosis-associated interstitial lung disease: identification of an early-stage CT findings.pubmed.ncbi.nlm.nih.gov
  47. Fleischner Society: Glossary of Terms for Thoracic Imaging.pubmed.ncbi.nlm.nih.gov
  48. Algorithmic Approach to the Diagnosis of Organizing Pneumonia: A Correlation of Clinical, Radiologic, and Pathologic Features.pubmed.ncbi.nlm.nih.gov
  49. Radiologic Abnormalities in Prolonged SARS-CoV-2 Infection: A Systematic Review.pubmed.ncbi.nlm.nih.gov
  50. Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review).pubmed.ncbi.nlm.nih.gov
  51. Medication-induced lung disease in children.pubmed.ncbi.nlm.nih.gov
  52. Non-metastatic causes of multiple pulmonary nodules.pubmed.ncbi.nlm.nih.gov
  53. Quantitative assessment of lung mechanical properties in ARDS using X-ray computed tomography.pubmed.ncbi.nlm.nih.gov
  54. CFD Modeling of Airflow and Aerosol Transport in the Human Respiratory System: A Comprehensive Review.pubmed.ncbi.nlm.nih.gov
  55. Polyphenol-enriched fraction of <i>Acacia seyal</i> Delile (Mimosaceae) inhibits human triple-negative breast cancer cells and exhibits anticancer and immunomodulatory effects in a DMBA-induced breast cancer model.pubmed.ncbi.nlm.nih.gov
  56. Invasive Pulmonary Aspergillosis-Mimicking <i>Pseudomonas aeruginosa</i> Pneumonia in Immunocompromised Patients: Radiologic Differentiation.pubmed.ncbi.nlm.nih.gov
  57. Invasive mucinous adenocarcinoma of the lung: integrating molecular landscape, imaging phenotypes, and translational therapeutic strategies.pubmed.ncbi.nlm.nih.gov
  58. A novel computed tomography-based multi-parameter decision tree algorithm model for preoperatively predicting the risk of lymph node metastasis in surgically resectable synchronous multiple primary lung cancer.pubmed.ncbi.nlm.nih.gov
  59. Adult Acute Respiratory Distress Syndrome (ARDS) Caused by Human Rhinovirus During Janus Kinase Inhibitor Therapy for Rheumatoid Arthritis: A Case Report and Literature Review.pubmed.ncbi.nlm.nih.gov
  60. ICU predictive factors of fibrotic changes following COVID-19 related ARDS: a RECOVIDS substudy.pubmed.ncbi.nlm.nih.gov
  61. Mixed Invasive <i>Aspergillus</i>-<i>Mucorales</i> Pulmonary Coinfection in a Diabetic Patient: An Uncommon Dual Fungal Pneumonia and Literature Review.pubmed.ncbi.nlm.nih.gov
  62. New developments in the biology of fibroblast growth factors.pubmed.ncbi.nlm.nih.gov
  63. Chronic Eosinophilic Pneumonia: A Pneumopathy With Many Faces.pubmed.ncbi.nlm.nih.gov
  64. Chronic Eosinophilic Pneumonia Masquerading as Non-resolving Upper Lobe Pneumonia.pubmed.ncbi.nlm.nih.gov
  65. Incidental Lung Lesions on the CT Component of Oncologic FDG PET/CT: A Pictorial Review of Interpretive Pitfalls and Diagnostic Clues.pubmed.ncbi.nlm.nih.gov
  66. Korean Guidelines for Diagnosis and Management of Interstitial Lung Disease: Cryptogenic Organizing Pneumonia.pubmed.ncbi.nlm.nih.gov
  67. Very severe aplastic anemia in a child with pulmonary mucormycosis: a case report.pubmed.ncbi.nlm.nih.gov
  68. Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions.pubmed.ncbi.nlm.nih.gov
  69. A mouse model of E-cigarette or vaping product use-associated lung injury (EVALI) induced by nose-only exposure to aerosolized vitamin E acetate and associated macrophage dysfunction.pubmed.ncbi.nlm.nih.gov
  70. Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer.pubmed.ncbi.nlm.nih.gov
  71. High-Resolution CT Findings in Interstitial Lung Disease Associated with Connective Tissue Diseases: Differentiating Patterns for Clinical Practice-A Systematic Review with Meta-Analysis.pubmed.ncbi.nlm.nih.gov
  72. Postinfluenza Organizing Pneumonia in an Older Adult Successfully Treated With Corticosteroids: A Case Report.pubmed.ncbi.nlm.nih.gov
  73. Late-Onset Mesalazine-Induced Eosinophilic Pneumonitis Presenting as Non-Resolving Pneumonia: A Diagnostic Pitfall in Ulcerative Colitis.pubmed.ncbi.nlm.nih.gov
  74. The first CT-based classification system for pulmonary actinomycosis: correlating imaging patterns with therapeutic strategies and prognosis in a highly misdiagnosed disease.pubmed.ncbi.nlm.nih.gov
  75. Ten Questions on Using Lung Ultrasonography to Diagnose and Manage Pneumonia in Hospital-at-Home Model: Part II-Confounders and Mimickers.pubmed.ncbi.nlm.nih.gov
  76. Case Report: Organizing pneumonia associated with AQP4-antibody neuromyelitis optica spectrum disorder in children.pubmed.ncbi.nlm.nih.gov
  77. Acute Fibrinous and Organizing Pneumonia Versus Organizing Pneumonia: A Comparative Study of Clinical, Radiological, Histological, and Immunophenotypic Features.pubmed.ncbi.nlm.nih.gov
  78. Case Report: Pulmonary brucellosis presenting as multiple cavitary lung lesions on imaging.pubmed.ncbi.nlm.nih.gov
  79. Beyond Infection and Malignancy: Diagnostic Pitfalls in Pulmonary Granulomatosis with Polyangiitis.pubmed.ncbi.nlm.nih.gov
  80. Diagnostic approach in acute hypoxemic respiratory failure.pubmed.ncbi.nlm.nih.gov
  81. Pulmonary Manifestations of Inflammatory Bowel Disease and Treatment Strategies.pubmed.ncbi.nlm.nih.gov
  82. Histologic patterns of chronic interstitial lung disease in dogs.pubmed.ncbi.nlm.nih.gov
  83. Imaging of pediatric pulmonary infections: A pictorial review.pubmed.ncbi.nlm.nih.gov
  84. Reversed halo sign: from a clinico-radiologic-pathologic point of view.pubmed.ncbi.nlm.nih.gov
  85. Pulmonary Manifestations in Patients With Hematologic Malignancies: In Pursuit of an Accurate Diagnosis.pubmed.ncbi.nlm.nih.gov
  86. Clinical features, management, and outcomes of pulmonary mucormycosis: a decade-long retrospective study from a single center in central China.pubmed.ncbi.nlm.nih.gov
  87. Migratory Pulmonary Infiltrates Mimicking Malignancy, Tuberculosis, and Sarcoidosis in an Apparently Immunocompetent Adult: A Case of Tissue-Proven Invasive Fungal Disease Due to a Non-<i>marneffei</i><i>Penicillium</i> Species.pubmed.ncbi.nlm.nih.gov
  88. CT manifestations of pulmonary mucormycosis: Influence of risk factor, symptom duration, and glycemic control.pubmed.ncbi.nlm.nih.gov
  89. Subacute invasive pulmonary aspergillosis following breast cancer treatment: A one-year diagnostic odyssey.pubmed.ncbi.nlm.nih.gov
  90. Imaging of Small Cell Lung Cancer: An Updated Overview of Current and Emerging Applications.pubmed.ncbi.nlm.nih.gov
  91. From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond.pubmed.ncbi.nlm.nih.gov
  92. Clinicopathologic Features of Isolated AFOP Nodules Radiologically Mimicking Malignancy in Post COVID-19 Patients: A Case Series Study.pubmed.ncbi.nlm.nih.gov
  93. Pneumonitis Associated with Immune Checkpoint Inhibitors and Targeted Anticancer Therapies: A Retrospective Case Series of 12 Patients.pubmed.ncbi.nlm.nih.gov
  94. Morphological computed tomography phenotypes in pulmonary sarcoidosis at diagnosis: splitting and lumping based on predictors of clinical progression.pubmed.ncbi.nlm.nih.gov
  95. Precise discrimination of mycobacterial pulmonary diseases via multimodal machine learning integrating chest CT and clinical markers.pubmed.ncbi.nlm.nih.gov
  96. Transfer learning with fuzzy decision support for multi-class lung disease classification: performance analysis of pre-trained CNN models.pubmed.ncbi.nlm.nih.gov
  97. Multimodality imaging of COVID-19 pneumonia: from diagnosis to follow-up. A comprehensive review.pubmed.ncbi.nlm.nih.gov
  98. Challenges in the Differential Diagnosis of COVID-19 Pneumonia: A Pictorial Review.pubmed.ncbi.nlm.nih.gov
  99. Peri- and intra-nodular radiomic features based on 18 F-FDG PET/CT to distinguish lung adenocarcinomas from pulmonary granulomas.pubmed.ncbi.nlm.nih.gov
  100. Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass.pubmed.ncbi.nlm.nih.gov
  101. Case Report: Neurogenic pulmonary edema coupled with myocardial damage following tenecteplase thrombolysis for acute ischemic stroke.pubmed.ncbi.nlm.nih.gov
  102. Point-of-Care Lung Ultrasound in Small Animal Emergency and Critical Care Medicine: A Clinical Review.pubmed.ncbi.nlm.nih.gov
  103. Establishment of seven lung ultrasound phenotypes: a retrospective observational study of an LUS registry.pubmed.ncbi.nlm.nih.gov
  104. Drug-Induced Pulmonary Toxicity in the Era of Immunotherapy and Biologics: A Narrative Review of Mechanism, Diagnosis, and Management.pubmed.ncbi.nlm.nih.gov
  105. Identification of imaging-based pulmonary and extrapulmonary treatable traits in COPD: a review.pubmed.ncbi.nlm.nih.gov
  106. AWMF S2k Guideline: Diagnosis and Assessment of Lung Disease Caused by Occupational Silica Dust Exposure (Silicosis) - Disease No. 4101 as per Occupational Diseases Ordinance (BKV) Annex 1.pubmed.ncbi.nlm.nih.gov
  107. Pediatric Congenital Lung Malformation: Advanced Imaging Techniques in Pre- and Neonatal Evaluation.pubmed.ncbi.nlm.nih.gov
  108. Conventional chest CT features are associated with Ki-67 labeling index in lung adenocarcinoma: a single-center retrospective radiopathologic study.pubmed.ncbi.nlm.nih.gov
  109. Pulmonary Edema: A Pictorial Review of Imaging Manifestations and Current Understanding of Mechanisms of Disease.pubmed.ncbi.nlm.nih.gov
  110. Lung imaging methods: indications, strengths and limitations.pubmed.ncbi.nlm.nih.gov
  111. Role of computed tomography in quantitative assessment of emphysema.pubmed.ncbi.nlm.nih.gov
  112. Comprehensive analysis of imaging and pathological features in 20 cases of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma: a retrospective study.pubmed.ncbi.nlm.nih.gov
  113. Postoperative Pulmonary Complications: Clinical and Imaging Insightspubmed.ncbi.nlm.nih.gov
  114. Imaging in patients with acute dyspnea when cardiac or pulmonary origin is suspected.pubmed.ncbi.nlm.nih.gov
  115. Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19.pubmed.ncbi.nlm.nih.gov

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez, tıbbi tavsiye değildir. Metinler yapay zekâ desteğiyle yazıldı ve otomatik bir adımda kaynak alıntılarıyla karşılaştırıldı; bu bir tıbbi doğrulama değildir ve içerik uzman radyolog incelemesinden geçmedi. Klinik kararlarda güncel kılavuzları, kurum protokollerini ve radyoloji raporunu esas alın.